SCHEMBL20816045

SCHEMBL20816045

COC(=O)c1cc(/C=C/C(=O)OCc2ccccc2)cn1S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.47
▸ CA12 O43570 2/20 0.45
▸ CA4 P22748 2/20 0.45
▸ CA6 P23280 2/20 0.45
▸ CA5A P35218 2/20 0.45
▸ CA7 P43166 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ CA14 Q9ULX7 2/20 0.45
▸ CA5B Q9Y2D0 2/20 0.45
▸ AKR1B10 O60218 2/20 0.45
▸ AKR1B1 P15121 2/20 0.45
▸ TTR P02766 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ NOS2 P35228 1/20 0.42
▸ MET P08581 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816036 0.83 MET (0.43) LMNACA12CA4CA6CA5A
SCHEMBL20816037 0.78 PTGS2 (0.42) CA12CA9MAPTALDH1A1MEN1
SCHEMBL20816040 0.76 OPRM1 (0.48) LMNATP53MAPTALDH1A1MEN1
SCHEMBL28993108 0.74 LMNA (0.79) LMNACA12CA4CA6CA5A
SCHEMBL28993111 0.74 LMNA (0.79) LMNACA12CA4CA6CA5A
SCHEMBL22300409 0.73 MEN1 (0.50) LMNAPOLBTP53MAPTMEN1
SCHEMBL12393137 0.72 HDAC1 (0.43) LMNACA9POLBMAPTALDH1A1
SCHEMBL28388377 0.69 LMNA (0.79) LMNACA12CA4CA6CA5A
SCHEMBL12393140 0.68 KDM4E (0.46) LMNACA9POLBMAPTALDH1A1
SCHEMBL25015538 0.68 OPRM1 (0.57) LMNAPOLBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577371-B2 Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) 2020-03-03 — — US disclosed
US-20190084987-A1 Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10577371-B2 Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof SUV39H2, SUV39H1, EZH1 LMNA 3237/4885CA12 3595/4885CA4 4038/4885
US-20190084987-A1 Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof SUV39H2, SUV39H1, EZH1 LMNA 3237/4885CA12 3595/4885CA4 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback